Sign in
8-K

Current Report

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-23-154338

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d350381d8k.htm…